Objectives:

1.Review pathophysiology of MASH and its relation to obesity
2.Discuss the benefits of weight loss in MASH
3.Review currently available and pipeline medications for MASH.

Session date: 
01/09/2025 - 7:00am to 8:00am CST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Holly F. Lofton, MD, Dipl.ABOM